These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27115412)

  • 1. Glucagon is the key factor in the development of diabetes.
    Lee YH; Wang MY; Yu XX; Unger RH
    Diabetologia; 2016 Jul; 59(7):1372-1375. PubMed ID: 27115412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon: acute actions on hepatic metabolism.
    Miller RA; Birnbaum MJ
    Diabetologia; 2016 Jul; 59(7):1376-1381. PubMed ID: 27115415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon action in the brain.
    Abraham MA; Lam TKT
    Diabetologia; 2016 Jul; 59(7):1367-1371. PubMed ID: 27115416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of leptin in diabetes: metabolic effects.
    Meek TH; Morton GJ
    Diabetologia; 2016 May; 59(5):928-32. PubMed ID: 26969486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.
    Unger RH; Cherrington AD
    J Clin Invest; 2012 Jan; 122(1):4-12. PubMed ID: 22214853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleotropic effects of leptin to reverse insulin resistance and diabetic ketoacidosis.
    Perry RJ; Petersen KF; Shulman GI
    Diabetologia; 2016 May; 59(5):933-7. PubMed ID: 26961503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic manifestations of insulin deficiency do not occur without glucagon action.
    Lee Y; Berglund ED; Wang MY; Fu X; Yu X; Charron MJ; Burgess SC; Unger RH
    Proc Natl Acad Sci U S A; 2012 Sep; 109(37):14972-6. PubMed ID: 22891336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice.
    Lee Y; Wang MY; Du XQ; Charron MJ; Unger RH
    Diabetes; 2011 Feb; 60(2):391-7. PubMed ID: 21270251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of glucagon and insulin action reveals a role for the GLP-1 receptor in endogenous glucose production.
    Jun LS; Millican RL; Hawkins ED; Konkol DL; Showalter AD; Christe ME; Michael MD; Sloop KW
    Diabetes; 2015 Mar; 64(3):819-27. PubMed ID: 25288673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid nanoparticle delivery of glucagon receptor siRNA improves glucose homeostasis in mouse models of diabetes.
    Neumann UH; Ho JSS; Chen S; Tam YYC; Cullis PR; Kieffer TJ
    Mol Metab; 2017 Oct; 6(10):1161-1172. PubMed ID: 29031717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectopic expression of glucagon receptor in skeletal muscles improves glucose homeostasis in a mouse model of diabetes.
    Maharaj A; Zhu L; Huang F; Qiu H; Li H; Zhang CY; Jin T; Wang Q
    Diabetologia; 2012 May; 55(5):1458-68. PubMed ID: 22318544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MST1: a promising therapeutic target to restore functional beta cell mass in diabetes.
    Ardestani A; Maedler K
    Diabetologia; 2016 Sep; 59(9):1843-9. PubMed ID: 27053234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human monoclonal antibodies against glucagon receptor improve glucose homeostasis by suppression of hepatic glucose output in diet-induced obese mice.
    Kim WD; Lee YH; Kim MH; Jung SY; Son WC; Yoon SJ; Lee BW
    PLoS One; 2012; 7(12):e50954. PubMed ID: 23226550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet cell function: alpha and beta cells--partners towards normoglycaemia.
    Göke B
    Int J Clin Pract Suppl; 2008 Mar; (159):2-7. PubMed ID: 18269435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist.
    Damond N; Thorel F; Moyers JS; Charron MJ; Vuguin PM; Powers AC; Herrera PL
    Elife; 2016 Apr; 5():. PubMed ID: 27092792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
    Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
    Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia.
    Conarello SL; Jiang G; Mu J; Li Z; Woods J; Zycband E; Ronan J; Liu F; Roy RS; Zhu L; Charron MJ; Zhang BB
    Diabetologia; 2007 Jan; 50(1):142-50. PubMed ID: 17131145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus.
    Hare KJ
    Dan Med Bull; 2010 Sep; 57(9):B4181. PubMed ID: 20816021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
    Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
    Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taurine supplementation ameliorates glucose homeostasis, prevents insulin and glucagon hypersecretion, and controls β, α, and δ-cell masses in genetic obese mice.
    Santos-Silva JC; Ribeiro RA; Vettorazzi JF; Irles E; Rickli S; Borck PC; Porciuncula PM; Quesada I; Nadal A; Boschero AC; Carneiro EM
    Amino Acids; 2015 Aug; 47(8):1533-48. PubMed ID: 25940922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.